• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

代谢组学特征及其与高血压和慢性肾脏病患者的氯沙坦、EXP3174 血浆水平和血压控制的相关性。

Metabolomic Profile and Its Correlation with the Plasmatic Levels of Losartan, EXP3174 and Blood Pressure Control in Hypertensive and Chronic Kidney Disease Patients.

机构信息

Graduate Program on Pharmaceutical Sciences, Department of Biological & Health Sciences, Federal University of Amapa, Macapa 68903-419, Brazil.

Laboratory of Quality Control, Bromatology and Microbiology, Department of Biological & Health Sciences, Federal University of Amapa, Macapa 68903-419, Brazil.

出版信息

Int J Mol Sci. 2023 Jun 7;24(12):9832. doi: 10.3390/ijms24129832.

DOI:10.3390/ijms24129832
PMID:37372980
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10298398/
Abstract

Systemic arterial hypertension (SAH) is one of the most prevalent chronic diseases worldwide and, when dysregulated, may cause serious complications. Losartan (LOS) blocks relevant physiological aspects of hypertension, acting mainly on the reduction of peripheral vascular resistance. Complications of hypertension include nephropathy, in which diagnosis is based on the observation of functional or structural renal dysfunction. Therefore, blood pressure control is essential to attenuate the progression of chronic kidney disease (CKD). In this study, H NMR metabolomics were used to differentiate hypertensive and chronic renal patients. Plasmatic levels of LOS and EXP3174, obtained by liquid chromatography coupled with mass-mass spectroscopy, were correlated with blood pressure control, biochemical markers and the metabolomic fingerprint of the groups. Some biomarkers have been correlated with key aspects of hypertension and CKD progression. For instance, higher levels of trigonelline, urea and fumaric acid were found as characteristic markers of kidney failure. In the hypertensive group, the urea levels found could indicate the onset of kidney damage when associated with uncontrolled blood pressure. In this sense, the results point to a new approach to identify CKD in early stages and may contribute to improving pharmacotherapy and reducing morbidity and mortality associated with hypertension and CKD.

摘要

系统性动脉高血压(SAH)是全球最普遍的慢性疾病之一,当其失调时可能会导致严重的并发症。氯沙坦(LOS)可阻断高血压的相关生理方面,主要作用于降低外周血管阻力。高血压的并发症包括肾病,其诊断基于对肾功能的功能性或结构性障碍的观察。因此,控制血压对于减轻慢性肾病(CKD)的进展至关重要。在这项研究中,我们使用核磁共振代谢组学来区分高血压和慢性肾病患者。通过液相色谱-质谱联用技术获得的氯沙坦和 EXP3174 的血浆水平与血压控制、生化标志物以及各组的代谢组指纹图谱相关联。一些生物标志物与高血压和 CKD 进展的关键方面相关。例如,较高水平的瓜氨酸、尿素和延胡索酸被认为是肾功能衰竭的特征性标志物。在高血压组中,与未控制的血压相关联时,发现的尿素水平可能表明肾脏损伤的发生。从这个意义上说,研究结果为识别早期 CKD 提供了一种新方法,并可能有助于改善药物治疗,降低与高血压和 CKD 相关的发病率和死亡率。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/10298398/fbc16d9394af/ijms-24-09832-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/10298398/d9f6f11e98a5/ijms-24-09832-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/10298398/f239b02a475d/ijms-24-09832-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/10298398/1368af6c33fd/ijms-24-09832-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/10298398/6ace865227f9/ijms-24-09832-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/10298398/115cf1d499af/ijms-24-09832-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/10298398/bdc8cc1af2bf/ijms-24-09832-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/10298398/fbc16d9394af/ijms-24-09832-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/10298398/d9f6f11e98a5/ijms-24-09832-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/10298398/f239b02a475d/ijms-24-09832-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/10298398/1368af6c33fd/ijms-24-09832-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/10298398/6ace865227f9/ijms-24-09832-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/10298398/115cf1d499af/ijms-24-09832-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/10298398/bdc8cc1af2bf/ijms-24-09832-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5147/10298398/fbc16d9394af/ijms-24-09832-g007.jpg

相似文献

1
Metabolomic Profile and Its Correlation with the Plasmatic Levels of Losartan, EXP3174 and Blood Pressure Control in Hypertensive and Chronic Kidney Disease Patients.代谢组学特征及其与高血压和慢性肾脏病患者的氯沙坦、EXP3174 血浆水平和血压控制的相关性。
Int J Mol Sci. 2023 Jun 7;24(12):9832. doi: 10.3390/ijms24129832.
2
Metabolomic Profile, Plasmatic Levels of Losartan and EXP3174, Blood Pressure Control in Hypertensive Patients and Their Correlation with COVID-19.代谢组学特征、氯沙坦及EXP3174的血浆水平、高血压患者的血压控制及其与COVID-19的相关性
Pharmaceuticals (Basel). 2023 Sep 13;16(9):1290. doi: 10.3390/ph16091290.
3
Effects of Single and Combined Losartan and Tempol Treatments on Oxidative Stress, Kidney Structure and Function in Spontaneously Hypertensive Rats with Early Course of Proteinuric Nephropathy.氯沙坦与替莫泊尔单一及联合治疗对早期蛋白尿性肾病自发性高血压大鼠氧化应激、肾脏结构和功能的影响
PLoS One. 2016 Aug 25;11(8):e0161706. doi: 10.1371/journal.pone.0161706. eCollection 2016.
4
The Beneficial Effects of Allicin in Chronic Kidney Disease Are Comparable to Losartan.大蒜素在慢性肾脏病中的有益作用可与氯沙坦相媲美。
Int J Mol Sci. 2017 Sep 16;18(9):1980. doi: 10.3390/ijms18091980.
5
Interim evidence of the renoprotective effect of the angiotensin II receptor antagonist losartan versus the calcium channel blocker amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for Global Renal Protection in Hypertensive Patients (JLIGHT) Study.血管紧张素II受体拮抗剂氯沙坦与钙通道阻滞剂氨氯地平对慢性肾病合并高血压患者肾脏保护作用的中期证据:日本高血压患者全球肾脏保护用氯沙坦治疗(JLIGHT)研究报告
Clin Exp Nephrol. 2003 Sep;7(3):221-30. doi: 10.1007/s10157-003-0241-3.
6
The impact of antihypertensive pharmacotherapy on interplay between protein-bound uremic toxin (indoxyl sulfate) and markers of inflammation in patients with chronic kidney disease.降压药物治疗对慢性肾脏病患者蛋白结合尿毒症毒素(硫酸吲哚酚)与炎症标志物相互作用的影响。
Int Urol Nephrol. 2019 Mar;51(3):491-502. doi: 10.1007/s11255-018-02064-3. Epub 2019 Jan 7.
7
FimAsartaN proTeinuriA SusTaIned reduCtion in comparison with losartan in diabetic chronic kidney disease (FANTASTIC): study protocol for randomized controlled trial.与氯沙坦相比,FimAsartaN可使糖尿病慢性肾病患者蛋白尿持续减少(FANTASTIC):一项随机对照试验的研究方案
Trials. 2017 Dec 29;18(1):632. doi: 10.1186/s13063-017-2375-8.
8
[Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].[卡托普利延缓自发性动脉高血压和阿霉素肾病大鼠慢性肾功能不全的进展]
Srp Arh Celok Lek. 2002 Mar-Apr;130(3-4):73-80. doi: 10.2298/sarh0204073j.
9
Blood pressure management in hypertensive people with non-dialysis chronic kidney disease in Queensland, Australia.澳大利亚昆士兰州非透析慢性肾病高血压患者的血压管理。
BMC Nephrol. 2019 Sep 4;20(1):348. doi: 10.1186/s12882-019-1532-6.
10
Renal protection of losartan 50 mg in normotensive Chinese patients with nondiabetic chronic kidney disease.氯沙坦 50 毫克对血压正常的中国非糖尿病慢性肾脏病患者的肾脏保护作用。
J Investig Med. 2012 Oct;60(7):1041-7. doi: 10.2310/JIM.0b013e31826741d2.

引用本文的文献

1
Metabolomic profiling of renal cyst fluid in advanced ADPKD: insights from dialysis and transplantation cohorts.晚期常染色体显性多囊肾病肾囊肿液的代谢组学分析:来自透析和移植队列的见解
Metabolomics. 2025 Jun 26;21(4):90. doi: 10.1007/s11306-025-02291-7.
2
Recent Advances in the Therapeutic Potential of Carotenoids in Preventing and Managing Metabolic Disorders.类胡萝卜素在预防和管理代谢紊乱方面治疗潜力的最新进展
Plants (Basel). 2024 Jun 7;13(12):1584. doi: 10.3390/plants13121584.
3
Metabolomic Profile, Plasmatic Levels of Losartan and EXP3174, Blood Pressure Control in Hypertensive Patients and Their Correlation with COVID-19.

本文引用的文献

1
Using MetaboAnalyst 5.0 for LC-HRMS spectra processing, multi-omics integration and covariate adjustment of global metabolomics data.使用 MetaboAnalyst 5.0 进行 LC-HRMS 光谱处理、多组学整合和全局代谢组学数据的协变量调整。
Nat Protoc. 2022 Aug;17(8):1735-1761. doi: 10.1038/s41596-022-00710-w. Epub 2022 Jun 17.
2
Brazilian Guidelines of Hypertension - 2020.《巴西高血压指南 - 2020》
Arq Bras Cardiol. 2021 Mar;116(3):516-658. doi: 10.36660/abc.20201238.
3
Using MetaboAnalyst 4.0 for Comprehensive and Integrative Metabolomics Data Analysis.
代谢组学特征、氯沙坦及EXP3174的血浆水平、高血压患者的血压控制及其与COVID-19的相关性
Pharmaceuticals (Basel). 2023 Sep 13;16(9):1290. doi: 10.3390/ph16091290.
使用MetaboAnalyst 4.0进行全面综合的代谢组学数据分析。
Curr Protoc Bioinformatics. 2019 Dec;68(1):e86. doi: 10.1002/cpbi.86.
4
H NMR based pharmacometabolomics analysis of metabolic phenotype on predicting metabolism characteristics of losartan in healthy volunteers.基于氢核磁共振波谱的代谢组学分析预测健康志愿者中洛沙坦代谢特征的代谢表型。
J Chromatogr B Analyt Technol Biomed Life Sci. 2018 Sep 15;1095:15-23. doi: 10.1016/j.jchromb.2018.07.016. Epub 2018 Jul 17.
5
High-Throughput Metabolomics by 1D NMR.基于一维 NMR 的高通量代谢组学。
Angew Chem Int Ed Engl. 2019 Jan 21;58(4):968-994. doi: 10.1002/anie.201804736. Epub 2018 Nov 11.
6
Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome.急慢性肝衰竭程度与肝肾综合征患者特利加压素和白蛋白反应的关系。
Clin Gastroenterol Hepatol. 2018 Nov;16(11):1792-1800.e3. doi: 10.1016/j.cgh.2018.01.035. Epub 2018 Jan 31.
7
2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ASPC/NMA/PCNA Guideline for the Prevention, Detection, Evaluation, and Management of High Blood Pressure in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.2017美国心脏病学会/美国心脏协会/美国医师协会/美国心脏病学学会/美国预防医学学院/美国老年病学会/美国药学协会/美国血液学会/美国预防医学学会/美国医学协会/美国初级保健医师学会成人高血压预防、检测、评估和管理指南:美国心脏病学会/美国心脏协会临床实践指南工作组报告
J Am Coll Cardiol. 2018 May 15;71(19):e127-e248. doi: 10.1016/j.jacc.2017.11.006. Epub 2017 Nov 13.
8
HMDB 4.0: the human metabolome database for 2018.HMDB 4.0:2018 年人类代谢组数据库。
Nucleic Acids Res. 2018 Jan 4;46(D1):D608-D617. doi: 10.1093/nar/gkx1089.
9
Metabolomic analysis of the saliva of Japanese patients with oral squamous cell carcinoma.日本口腔鳞状细胞癌患者唾液的代谢组学分析。
Oncol Rep. 2017 May;37(5):2727-2734. doi: 10.3892/or.2017.5561. Epub 2017 Apr 6.
10
Branched-Chain Amino Acids as Predictors for Individual Differences of Cisplatin Nephrotoxicity in Rats: A Pharmacometabonomics Study.支链氨基酸作为大鼠顺铂肾毒性个体差异的预测指标:一项药物代谢组学研究
J Proteome Res. 2017 Apr 7;16(4):1753-1762. doi: 10.1021/acs.jproteome.7b00014. Epub 2017 Mar 17.